Stryker Bets On OP-1 Putty After Encountering A Tough Orthopedic Climate
This article was originally published in The Gray Sheet
Executive Summary
Stryker says that its OP-1 Putty bone morphogenetic protein will sustain growth levels as its hips and knee products encounter an increasingly challenging pricing environment